The global cardiac drug stent market size was USD 9.93 Billion in 2022 and is expected to register a revenue CAGR of 5.9% during the forecast period. Rising prevalence of cardiovascular diseases, shifting preference toward minimally invasive therapeutic procedures, speedy evaluation, and approval of cardiac drug stents, along with incorporation of technological innovations in stent mechanism...